| CDE ID | CDE Description | | * 421 | EDRN Participant ID (Go To: 423) |
| * 423 | EDRN Protocol ID (Go To: 422) |
| * 422 | EDRN Site ID (Go To: 929) |
| * 929 | EDRN Staff ID of the person who collected the data: (Go To: 968) |
| * 968 | Date of procedure that generated pathology report (MM/DD/YYYY): (Go To: 844) |
| * 844 | Date pathology report completed (MM/DD/YYYY): (Go To: 706) |
| * 706 | Method of acquisition (Go To: 839) |
| | | Permissible Values (value): | Biopsy (1) |
|
| | | | Excised during surgery (2) |
|
| | |
| 839 | ID number of local pathology report: (Go To: 3214) |
| * 3214 | Number of subform loops to record 2: (Go To: 3201) |
| | | Permissible Values (value): | 1 (1) |
|
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| * 3201 | Line number or identifier 2 (system-generated): (Go To: 3305) |
| * 3305 | Pancreatic cyst or lesion pathology: (Go To: 3163) |
| | | Permissible Values (value): | IPMN (2) (Go To: 3313) |
|
| | |
| | | | Microcystic adenoma (serous cystadenoma) (5) |
|
| | |
| | |
| | | | Solid pseudopapillary tumor (9) (Go To: 3307) |
|
| | | | Cystic neuroendocrine tumor (10) (Go To: 3314) |
|
| | | | Adenocarcinoma (11) (Go To: 3307) |
|
| | | | Other, specify: (97) (Go To: 3315) |
|
| * 3315 | Cyst/lesion pathology (Other, specify:) (Go To: 3311) |
| * 3313 | Ductal involvement: (Go To: 3310) |
| | | Permissible Values (value): | Branched (2) |
|
| | |
| | |
| | |
| * 3310 | IPMN sub-type: (Go To: 3306) |
| | | Permissible Values (value): | Gastric foveolar (1) |
|
| | |
| | | | Intraductal tubulopapillary neoplasm (3) |
|
| | | | Intraductal oncocytic papillary neoplasm (4) |
|
| | |
| | |
| * 3306 | Degree of dysplasia (cyst): (Go To: 3311) |
| | | Permissible Values (value): | Low grade (1) |
|
| | |
| | |
| | |
| * 3311 | Associated with invasive carcinoma? (Go To: 3163) |
| | | Permissible Values (value): | No (0) |
|
| | |
| | |
| * 3312 | Type of invasiveness: (Go To: 3309) |
| | | Permissible Values (value): | Microinvasive carcinoma, mucinous (colloid) (1) |
|
| | | | Microinvasive carcinoma, tubular (ductal) (2) |
|
| | | | Invasive carcinoma, mucinous (colloid) (3) |
|
| | | | Invasive carcinoma, tubular (ductal) (4) |
|
| | |
| * 3309 | Size of largest focus on invasion (mm): (Go To: 3307) |
| * 3314 | Grading for cystic neuroendocrine tumor: (Go To: 3307) |
| | | Permissible Values (value): | G1 (1) |
|
| | |
| | |
| | |
| * 3307 | Pancreatic T-stage, pathologic: (Go To: 3308) |
| | | Permissible Values (value): | TX (7) |
|
| | |
| | |
| | |
| | |
| | |
| | |
| * 3308 | Pancreatic N-stage, pathologic: (Go To: 3163) |
| | | Permissible Values (value): | NX (1) |
|
| | |
| | |
| 3163 | Loop-specific comments 2: (Go To: 1097) |
| 1097 | Comments (do not include any participant identifiers) (Go To: End of Form) |